As the population of People Living with Human Immunodeficiency Virus (PLWH) ages in the era of effective antiretroviral therapy, the risk of non-HIV associated cancers is increasing, and now accounts for most cancer diagnosed in PLWH. Moreover, PLWH experience worse outcomes compared with individuals with similar cancer who do not have HIV infection. In addition, most clinical trials testing novel therapeutic agents excluded PLWH, including immunotherapeutic approaches that have revolutionized cancer therapy.
Leadership
Current responsibilities of the Laboratory Resources Committee include:
- Reviewing proposed correlative studies for AMC protocols
- Monitoring ongoing analyses of biospecimens
- Standardizing assay data
- Participating in scientific matters for the NRLs and AMC Biorepositories
- Overseeing the AMC Domestic Biorepository to assemble and ship biospecimen collection kits